Tagged ‘ICH’
Journal Review
Intensive Blood Pressure Lowering in Intracerebral Hemorrhage (ATACH-2 Trial)
Hemorrhagic stroke accounts for only 11-22% of all strokes but up to 50% of all stroke mortality. Additionally, there is significant disability associated with the disease in survivors. Much of our attention in the Emergency Department is guided towards preventing expansion of bleeding and secondary injury after the initial insult.
Read More
Journal Review
Platelet Transfusion in Spontaneous Intracerebral Hemorrhage on Antiplatelet Agents (PATCH Trial)
Spontaneous, non-traumatic, intracerebral hemorrhagic strokes accounts for 11-22% of incidence strokes but 50% of all stroke deaths. There are about 2 million of these bleeds a year world-wide. Many patients with these types of bleeds and strokes in general will be on anti platelet agents like aspirin and clopidogrel.
Read More
Journal Review
Immediate + Delayed ICH in Patients on Warfarin or Clopidogrel
Warfarin and clopidogrel are two commonly prescribed anticoagulant medications, and based on previous studies, patients taking either of these medications who suffer blunt head trauma are at an increased risk for traumatic intracranial hemorrhage (ICH).
Read More